Recovery · Reference
BPC-157 Dosage: How Pepti Prescribes It, in Units, mL, mg and mcg
This page explains the BPC-157 dosage Pepti prescribes, what the units on the syringe mean, a dosage chart that converts units to millilitres, milligrams and micrograms, how a BPC-157 injection is given, how long a vial lasts, the dosage of the BPC-157 + TB-500 combination, what the published research does and does not say about dose, and the side effects to know about. It describes how Pepti's BPC-157 is typically prescribed, not dosing protocols from forums. Nothing here is a reason to change your own dose.

At Pepti, BPC-157 is prescribed as 0.18 mL, which is 18 units on a U-100 insulin syringe, injected under the skin once daily. The vial is 5 mL at 1 mg/mL, so each dose carries 0.18 mg (180 mcg) of BPC-157 and the vial holds 27 doses, just under four weeks. The BPC-157 + TB-500 vial is dosed differently: 0.25 mL (25 units) Monday through Friday mornings, 0.25 mg of each peptide per dose. Your physician sets your directions after reviewing your intake, and your exact dose is printed on the vial.
This page explains the BPC-157 dosage Pepti prescribes, what the units on the syringe mean, a dosage chart that converts units to millilitres, milligrams and micrograms, how a BPC-157 injection is given, how long a vial lasts, the dosage of the BPC-157 + TB-500 combination, what the published research does and does not say about dose, and the side effects to know about. It describes how Pepti's BPC-157 is typically prescribed, not dosing protocols from forums. Nothing here is a reason to change your own dose.
BPC-157 Dosage
The short answer
| Product | Vial | Typical directions | Per dose | Doses per vial | Price |
|---|---|---|---|---|---|
| BPC-157 | 5 mL, 1 mg/mL (5 mg per vial) | Inject 0.18 mL (18 units) subcutaneously once daily as directed | 0.18 mg (180 mcg) BPC-157 | 27 | $209/mo |
| BPC-157 + TB-500 | 5 mL, 1 mg/mL of each (5 mg BPC-157 and 5 mg TB-500 per vial) | Inject 0.25 mL (25 units) subcutaneously Monday through Friday mornings | 0.25 mg BPC-157 and 0.25 mg TB-500 | 20 | $259/mo |
Every price is all-in, covering medication, physician review, refill management and shipping, with no separate membership fee. Pepti is cash-pay and does not bill insurance. These are the typical printed directions; your own directions are the ones on your vial.
BPC-157 Dosage
BPC-157 dosage in units, mL, mg and mcg
Pepti's directions are written in two forms, millilitres and units, because prescriptions are written in millilitres and insulin syringes are marked in units. On a U-100 insulin syringe, 1 unit is 0.01 mL, so 100 units is 1 mL and 18 units is 0.18 mL. A unit is a volume mark on the barrel, not a measure of how strong the medication is. The question "how many units of BPC-157" only has an answer alongside the concentration on the label.
The milligram figure comes from that concentration. Pepti's BPC-157 is supplied at 1 mg/mL, so:
| What you read | Value | Where it comes from |
|---|---|---|
| Dose volume | 0.18 mL | Printed on the vial |
| On a U-100 insulin syringe | 18 units | 0.18 mL x 100 units per mL |
| Concentration | 1 mg/mL | Printed on the vial |
| BPC-157 per dose | 0.18 mg, which is 180 mcg | 1 mg/mL x 0.18 mL |
| Total in the vial | 5 mg in 5 mL | Printed on the vial |
| Doses per vial | 27 | 5 mL divided by 0.18 mL, rounded down to whole doses |
That arithmetic is a way to read a label, not a way to set a dose. A vial labelled 5 mg is not a 5 mg dose: it is twenty-seven 0.18 mg doses. Online dosing is usually quoted in micrograms, which is why the micrograms are shown here: 1 mg is 1,000 mcg, so 0.18 mg is 180 mcg. If your label and your syringe seem to disagree, do not dose; message your care team. How long does a peptide vial last explains every number on a vial label in more detail.
BPC-157 Dosage
BPC-157 dosage chart: units to mL to mg
People search for a "BPC-157 dosage chart" because online charts mix units, micrograms and milligrams freely, and the numbers only line up if you know the concentration. The chart below is the conversion for a 1 mg/mL vial, drawn with a U-100 insulin syringe. It is math only. It is not a menu of doses, and the only line that applies to you is the one that matches the number printed on your vial.
| Syringe mark (U-100) | Volume | BPC-157 from a 1 mg/mL vial | In micrograms |
|---|---|---|---|
| 5 units | 0.05 mL | 0.05 mg | 50 mcg |
| 10 units | 0.1 mL | 0.1 mg | 100 mcg |
| 15 units | 0.15 mL | 0.15 mg | 150 mcg |
| 18 units (Pepti's typical directions) | 0.18 mL | 0.18 mg | 180 mcg |
| 20 units | 0.2 mL | 0.2 mg | 200 mcg |
| 25 units | 0.25 mL | 0.25 mg | 250 mcg |
| 30 units | 0.3 mL | 0.3 mg | 300 mcg |
| 50 units | 0.5 mL | 0.5 mg | 500 mcg |
| 100 units | 1 mL | 1 mg | 1,000 mcg |
The rule behind every row: at 1 mg/mL, units divided by 100 gives both millilitres and milligrams, and units multiplied by 10 gives micrograms. That neat equivalence only holds at 1 mg/mL. A chart written for a research powder mixed at a different strength will give different figures for the same units, which is the main reason not to dose from a chart, including this one.
The Pen
BPC-157 also comes as a 3 mL pre-filled pepti Pen cartridge containing 9 mg of BPC-157, used in a reusable click-dial injector. It is dosed by the pen's dial rather than drawn with a syringe, so the units chart above does not apply to it; the Pen directions come printed with your prescription. It is the same medication, and the comparison is in vial vs pen. The Pen is sold into every state Pepti serves except Alabama.
BPC-157 Dosage
How a BPC-157 injection is given
A BPC-157 injection is a small subcutaneous injection: a fine, short needle into the fat layer under the skin, not into the muscle and never into a vein. Pepti's vial arrives as a ready-to-use multi-dose solution, so there is no powder to reconstitute and no bacteriostatic water to add. Sterile syringes and alcohol prep pads come with it.
| Directions say | What it means in practice |
|---|---|
| 0.18 mL (18 units) | Draw to the 18 mark on a U-100 insulin syringe |
| Subcutaneously | Into the fat layer, abdomen or thigh, rotating sites |
| Once daily | One injection a day, at a consistent time |
| As directed | Follow anything else your directions add; they are the instructions that apply |
| 27 doses per vial | Just under four weeks, then the next refill |
Where to inject BPC-157
Abdomen and thigh are the usual sites, rotated so the same spot is not used repeatedly. People often ask whether BPC-157 should be injected near the injury. Some prescribers have directed injection near the affected area on the theory that local concentration matters; others do not, because the mechanisms described in the research are systemic. Pepti's standard directions are subcutaneous at the usual sites. If your directions say something different, follow your directions. Technique, from cleaning the stopper to disposing of the syringe, is in how to inject peptides safely.
Oral BPC-157 versus injection
BPC-157 is unusual among peptides in being described as stable in gastric juice, which is why oral forms have been studied at all. Capsules sold as supplements are a different product from a compounded injection in form, dose, route and oversight, and there is no human data for the oral route. Pepti supplies BPC-157 as an injection.
BPC-157 Dosage
How long a BPC-157 vial lasts
At Pepti's typical directions, one 5 mg vial lasts just under four weeks:
| Step | Value |
|---|---|
| Dose | 18 units, 0.18 mL, 0.18 mg |
| Doses per week | 7 (once daily) |
| Doses per vial | 27 (5 mL divided by 0.18 mL, whole doses only) |
| BPC-157 used | 27 x 0.18 mg = 4.86 mg of the 5 mg |
| Time per vial | 27 days |
Refills run every 28 days, one vial per fill. A small remainder stays in every vial because the last partial dose cannot be drawn accurately. If a vial runs short before the refill, message your care team rather than adjusting anything yourself. If you miss a dose, follow your directions and do not take two doses to make up for one.
Vials ship refrigerated with ice packs and stay in the fridge between doses. Follow the beyond-use date printed on the label, which runs from first puncture. How to store peptides covers storage.
BPC-157 Dosage
BPC-157 + TB-500 dosage
BPC-157 and TB-500 are often prescribed together, a pairing known online as the Wolverine stack. Pepti compounds them into one vial, and its directions differ from BPC-157 alone:
| BPC-157 alone | BPC-157 + TB-500 | |
|---|---|---|
| Vial | 5 mL, BPC-157 1 mg/mL | 5 mL, BPC-157 1 mg/mL + TB-500 1 mg/mL |
| Typical directions | 0.18 mL (18 units) once daily | 0.25 mL (25 units) Monday through Friday mornings |
| BPC-157 per dose | 0.18 mg | 0.25 mg |
| TB-500 per dose | None | 0.25 mg |
| Doses per vial | 27 | 20 |
| Doses per week | 7 | 5 |
| Price | $209/mo | $259/mo |
Each 25 unit draw from the combination vial delivers both peptides together in a fixed 1:1 ratio; there is no way to take more of one and less of the other from the same vial. Twenty weekday doses is four weeks, matching the 28-day refill. The combination also comes as a 3 mL Pen cartridge containing 9 mg BPC-157 and 13.5 mg TB-500, a different ratio from the vial, so the Pen directions are written separately.
Two blends carry the same pair at twice the concentration plus other components, each drawn at 0.25 mL (25 units) Monday through Friday mornings:
| Blend | What is in the 5 mL vial | BPC-157 and TB-500 per 0.25 mL | Price |
|---|---|---|---|
| GLOW | 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500 | 0.5 mg of each | $259/mo |
| KLOW | 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, 10 mg TB-500 | 0.5 mg of each | $259/mo |
How the pair works, what research describes and how the blends compare are in Wolverine stack, what is BPC-157 + TB-500 and KLOW vs GLOW.
BPC-157 Dosage
What the research used, and why that is not your dose
Search results for "BPC-157 dosage" are full of microgram-per-kilogram figures and protocols. It is worth knowing where those numbers come from, because almost none of them come from people.
| Source | Who | What it says about dose |
|---|---|---|
| Rat tendon, ligament and muscle studies, Journal of Orthopaedic Research, 2003 to 2010 | Rats | Doses chosen for animal models, given by injection, in drinking water or as a cream |
| Formal toxicology, Regulatory Toxicology and Pharmacology, 2020 | Rats and dogs | No acute toxicity at single doses of 20 mg/kg in rats and 10 mg/kg in dogs, and no organ changes in 28-day studies at up to 4.0 mg/kg daily in rats; doses far above anything prescribed, given intramuscularly |
| Human studies found by the FDA's 2026 review | 32 healthy volunteers, 53 people with ulcerative colitis, 17 with knee pain, 12 women with interstitial cystitis, 2 by vein | Enema, into the knee joint, into the bladder wall, or intravenous; none used subcutaneous injection |
The honest reading: there is no human dose-ranging study of injectable BPC-157. The FDA found no human study of subcutaneous BPC-157 and no human data on how much of an injected dose reaches the blood. The animal work describes a wide margin between effective doses and doses that cause problems, which is the basis of its tolerability reputation, but an animal dose does not translate into a human one by simple arithmetic. Any protocol claiming a proven human dose is overstating the evidence. That is why your directions come from a physician who has reviewed your intake, not from a study table or a forum. The evidence, claim by claim, is in BPC-157 benefits.
BPC-157 Dosage
What changes the directions
Your physician sets your directions after reviewing your intake. Things that can lead to different directions, or a different product, include:
| What can change | How it shows up |
|---|---|
| BPC-157 alone or with TB-500 | The combination vial has its own label: 25 units on weekday mornings |
| A blend instead | GLOW and KLOW carry 2 mg/mL of BPC-157, so the same draw delivers more |
| Vial or Pen | The Pen is dosed by dial instead of syringe units |
| Your medical history | A cancer history, blood thinners, pregnancy or breastfeeding change the conversation |
| Your other medications | There is no established interaction list, so the intake asks for everything you take |
| How you respond | Side effects go to your care team, who may revise your directions |
When directions change, the new numbers are printed on the new label. Never carry a number over from a previous fill. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
BPC-157 Dosage
Side effects, in summary
The full safety picture is in is BPC-157 safe.
| What is reported | How often | What to do |
|---|---|---|
| Injection-site redness, itching, tenderness or a small firm lump | Common | Rotate sites between abdomen and thigh; mention it at follow-up |
| Mild fatigue or headache in the first week or two | Common | Mention it; it usually settles |
| Nausea or light-headedness shortly after a dose | Uncommon | Report it to your care team; do not change the dose yourself |
| A site that is hot, spreading or more painful after 48 hours; bleeding away from the site | Uncommon | Stop dosing and contact your physician the same day |
| Swelling of the face, lips or throat, widespread rash, difficulty breathing | Rare | Emergency care first (call 911), then tell your physician |
Who should not take BPC-157, or should discuss it first: anyone with an active or recent cancer, because of the blood vessel growth mechanism described in the research; anyone on blood thinners, because the FDA flagged clotting-time changes in animal studies; and anyone pregnant or breastfeeding, where no safety data exists. BPC-157 is named on the 2026 WADA Prohibited List under S0, prohibited at all times, so tested athletes should tell their physician before starting; see is BPC-157 banned.
On 15 April 2026 the FDA removed BPC-157 from Category 2 of its 503A bulk substances list, and on 23 July 2026 its Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding it to the 503A Bulks List; the FDA's final determination is pending. It remains legal to prescribe and dispense. Compounded BPC-157 is not FDA approved, and compounded medications are not FDA approved.
BPC-157 Dosage
Where to get BPC-157 prescribed
BPC-157 cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested, so even the concentration your units chart depends on is unknown, and research powders have to be mixed at home. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and dose changes.
Pepti prescribes BPC-157 in every state except Oklahoma, plus DC Step by step: how to get BPC-157 prescribed online and how to get BPC-157 + TB-500 prescribed online. The full product reference is what is BPC-157. How it compares with its usual partners: BPC-157 vs TB-500 and KPV vs BPC-157.
References
What this is based on.
References
- Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts · Molecules (2014) · PMID 25415472
- Krivic A, Anic T, Seiwerth S, et al.. Achilles detachment of rat and stable gastric pentadecapeptide BPC 157 · Journal of Orthopaedic Research (2006) · PMID 16583442
- Sikiric P, Seiwerth S, Rucman R, et al.. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract · Current Pharmaceutical Design (2011) · PMID 21548867
- Cerovecki T, Bojanic I, Brcic L, Radic B, et al.. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat · J Orthop Res (2010) · PMID 20225319
- Sikiric P, Seiwerth S, Rucman R, Turkovic B, et al.. Stable gastric pentadecapeptide BPC 157-NO-system relation · Curr Pharm Des (2014) · PMID 23755725
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H · Drug Test Anal (2017) · PMID 28035768
- Thomas A, Görgens C, Guddat S et al.. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry · J Sep Sci (2016) · PMID 26578461
- Farrar JT, Young JP Jr, LaMoreaux L, Werth JL et al.. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale · Pain (2001) · PMID 11690728
- Meyer JD, Ho B, Manning MC. Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides · Pharm Biotechnol (2002) · PMID 11987755
- Xu C, Sun L, Ren F, Huang P, et al.. Preclinical Safety Evaluation of Body Protective Compound-157, a Potential Drug for Treating Various Wounds · Regul Toxicol Pharmacol (2020) · PMID 32334036
- He L, Feng D, Guo H, et al.. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs · Front Pharmacol (2022) · PMID 36588717
- Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain · Altern Ther Health Med (2021) · PMID 34324435
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
BPC-157 Dosage, answered.
At Pepti, BPC-157 is typically prescribed as 0.18 mL, which is 18 units on a U-100 insulin syringe, injected subcutaneously once daily. From the 1 mg/mL vial that is 0.18 mg, or 180 mcg, per dose. Your physician sets your directions after reviewing your intake, and your exact dose is printed on the vial.
The amount printed on your vial, on the schedule printed on your vial. Pepti's typical directions are 18 units once daily, but your own directions are set by your physician after reviewing your intake. If you have questions about your dose, message your care team.
The number printed on your vial. Pepti's typical directions for BPC-157 alone are 18 units, which is 0.18 mL on a U-100 insulin syringe. The BPC-157 + TB-500 vial is typically 25 units.
From a 1 mg/mL vial, 180 mcg (0.18 mg). 10 units is 100 mcg and 25 units is 250 mcg. Those figures only hold at 1 mg/mL; a different concentration gives different amounts for the same units.
The chart above converts units to millilitres, milligrams and micrograms for a 1 mg/mL vial, the concentration Pepti supplies. It is a conversion, not a list of doses to choose from. Your own label is the one that applies.
Under the skin, into the fat layer of the abdomen or thigh, rotating sites. Pepti's standard directions are subcutaneous at the usual sites because the mechanisms described in the research are systemic. If your directions say otherwise, follow your directions.
27 days. A 5 mg vial at 18 units (0.18 mL) once daily holds 27 whole doses. Refills run every 28 days, one vial per fill.
Pepti's combination vial is typically 0.25 mL (25 units) subcutaneously Monday through Friday mornings, which delivers 0.25 mg of BPC-157 and 0.25 mg of TB-500 per dose, 20 doses per vial. More on the pairing is in Wolverine stack.
No. Pepti vials are multi-dose solutions shipped ready to use, with sterile syringes and alcohol prep pads. Research powders are the products that need mixing; see BAC water for peptides.
No. Take the dose printed on your vial, on the schedule printed on your vial. There is no human study showing that a larger dose does more. If you have questions about your dose, message your care team.
No. There is no human dose-ranging study of injectable BPC-157, and the FDA found no human study of subcutaneous BPC-157. Protocols online are built from animal studies and practice, not human trials.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.



